The ACMT Connection Enews > ACMT Collaborates with MENATOX

ACMT Collaborates with MENATOX

ACMT Collaborates with MENATOX in Muscat, Oman — March 21-24, 2018

The Middle East and North Africa Clinical Toxicology Association (MENATOX) partnered with the Oman Ministry of Health and its National Center for Disease Control, Department of Environmental and Occupational Health in organizing the 7th Annual MENATOX Conference in Muscat, Oman between March 21-24, 2018. The conference was attended by approximately 150 participants from Bahrain, France, Iraq, India, Turkey, Kazakhstan, Lebanon, New Zealand, Oman, Palestine, Qatar, Saudi Arabia, Sudan, United Arab Emirates, United Kingdom, United States of America and Yemen. The conference focused on challenges that confront the MENA region. These include the development of the specialties of medical and clinical toxicology as well as poisoning prevention, chemical hazard mitigation, building analytical toxicology lab capacity, use of chemical warfare agents in conflicts and poison center resource development in the region.

The Ministry of Health in Oman has collaborated with MENATOX since 2016 and has recently opened its poison center that includes two medical toxicologists, Drs. Badria Alhatali and Nadia Alhajri, who are both MENATOX and ACMT members. MENATOX was formed in 2010 to advance the care of poisoned patients, prevent poisoning from drugs, chemical hazards and radiation and establish the specialties of medical and clinical toxicology in the MENA region. The board of directors is composed of Drs. Ziad Kazzi (President), Nadeem Alduaij (Executive Director), Badria Alhatali (Treasurer), Robert J. Hoffman (Secretary), Bruno Megarbane, Mohammed Almalki and Nahar Alrewaili.

The American College of Medical Toxicology (ACMT) collaborated closely with the organizers and contributed several plenary and educational sessions through Drs. Michael Kosnett (FACMT and ACMT Past President), Brent Morgan (FACMT), and Charles McKay (FACMT and ACMT President). Additionally, Dr. Ziad Kazzi, FACMT, president of MENATOX, serves on the boards of ACMT and the Medical Toxicology Foundation. ACMT faculty participated in a number of panels while Dr. Kosnett gave a plenary address discussing the need for setting new occupational lead exposure regulations. Through funding from CRDF-Global, ACMT delivered the Agents for Opportunity for Terrorism to approximately 140 participants and moderated simulation-based sessions on chemical warfare agents. Several members of the conference faculty, organizing committee and MENATOX board of directors are joint members of MENATOX and ACMT.

ACMT is committed to the development of the specialty of medical toxicology and to the advancement of toxicologic care globally through education and research. This close collaboration with MENATOX, a relatively new yet vibrant organization, is a step forward in this exciting and worthwhile journey.